EN | UA
EN | UA

Help Support

Back

Gastroenterology

Filter By Diseases (0)

How much time do you have? in mins

All Content

129
Summaries

Myo-inositol for GDM prevention: What the latest evidence reveals...

Myo-inositol substantially lowers the incidence of gestational diabetes, improves glucose tolerance, and reduces risks of preterm birth and pregn...

105
Summaries

Long-term benefits of ligation-assisted antireflux mucosectomy in...

ARMS-L significantly alleviates GERD symptoms and enhances long-term quality of life, especially in PPI-dependent patients with cardioesophageal...

138
Medical News

Trial supports steamed ginger extract for better digestive health

GGE03, a steamed ginger extract, effectively relieves abdominal pain, constipation, indigestion, and reflux while enhancing overall health and we...

167
Medical News

European experts release guidelines for functional bloating and a...

Functional bloating and abdominal distension should be managed through a structured, evidence-based approach combining clinical diagnosis, target...

147
Medical News

Tegoprazan matches PPI healing rates in erosive esophagitis

Tegoprazan redefines treatment for erosive esophagitis, delivering results on par with PPIs while drawing focus to the evaluation of its long-ter...

149
Medical News

Real-world data raise concerns over PPI safety in infants

A new FAERS analysis raises concern over the safety of PPIs in infants, showing that drugs like lansoprazole increase the risk of adverse events...

73
Medical News

Droplet digital PCR offers accurate prediction of H. pylori eradi...

Using droplet digital PCR to detect clarithromycin resistance in stored urease test samples serves as a dependable indicator of H. pylori therapy...

153
Summaries

Tegoprazan vs. proton pump inhibitors: Comparative analysis of he...

Tegoprazan is associated with a reduced risk of liver injury when compared with traditional proton pump inhibitors.

99
Medical News

Tegoprazan outperforms lansoprazole in healing erosive esophagiti...

Tegoprazan 50 mg offers rapid, consistent, and superior healing benefits in erosive esophagitis compared to lansoprazole 30 mg.

132
Medical News

Is gastric acid testing unnecessary for most MEN1-ZES patients?

For MEN1-ZES management, symptom-driven endoscopy may provide more meaningful guidance than routine gastric acid testing, streamlining surveillan...

113
Summaries

Comorbid GERD as a determinant of symptom burden in LPRD

GERD worsens the symptom burden in LPRD, with age, female sex, smoking, and alcohol use driving the risk of comorbidity.

123
Summaries

Clinical and economic value of vonoprazan vs. tegoprazan for GERD

For GERD management, both vonoprazan and tegoprazan illustrate favorable overall value, with vonoprazan performing marginally better across econo...

Try: